The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Natural products as leads to anticancer drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Faulkner, D. J. (1990) · Natural Product Reports · doi:10.1039/np9900700269 · Cited by 4,866
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Saltz, L. B., Cox, J. V., Blanke, C., Rosen, L. S., Fehrenbacher, L., Moore, M. J., Maroun, J. A., Ackland, S. P., Locker, P. K., Pirotta, N., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431302 · Cited by 3,005
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.
Hsiang, Y. H., Hertzberg, R., Hecht, S., & Liu, L. F. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38654-4 · Cited by 2,362
Wall, M. E., Wani, M. C., Cook, C. E., Palmer, K. H., McPhail, A. T., & Sim, G. A. (1966) · Journal of the American Chemical Society · doi:10.1021/ja00968a057 · Cited by 2,258
Plants as a source of anti-cancer agents
Cragg, G. M., & Newman, D. J. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.05.011 · Cited by 2,034
The role of natural product chemistry in drug discovery
Butler, M. S. (2004) · Journal of Natural Products · doi:10.1021/np040106y · Cited by 1,381
Lessons from natural molecules
Clardy, J., & Walsh, C. (2004) · Nature · doi:10.1038/nature03194 · Cited by 1,171
Nicolaou, K. C., Yang, Z., Liu, J. J., Ueno, H., Nantermet, P. G., Guy, R. K., Claiborne, C. F., Renaud, J., Couladouros, E. A., Paulvannan, K., et al. (1994) · Nature · doi:10.1038/367630a0 · Cited by 1,096
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Marine Natural Products and Related Compounds in Clinical and Advanced Preclinical Trials
Newman, D. J., & Cragg, G. M. (2004) · Journal of Natural Products · doi:10.1021/np040031y · Cited by 759
Marine natural products as anticancer drugs
Simmons, T. L., Andrianasolo, E., McPhail, K., Flatt, P., & Gerwick, W. H. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.333.4.2 · Cited by 597
The Renaissance of Natural Products as Drug Candidates
Paterson, I., & Anderson, E. A. (2005) · Science · doi:10.1126/science.1116364 · Cited by 559
Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives
Gordaliza, M., Garcı́a, P. A., Miguel del Corral, J. M., Castro, M. A., & Gómez-Zurita, M. A. (2004) · Toxicon · doi:10.1016/j.toxicon.2004.05.008 · Cited by 548
Self-citationFrom traditional Chinese medicine to rational cancer therapy
Efferth, T., Li, P. C. H., Konkimalla, V. S. B., & Kaina, B. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.07.001 · Cited by 528
Kingsbury, W. D., Boehm, J. C., Jakas, D. R., Holden, K. G., Hecht, S. M., Gallagher, G., Caranfa, M. J., McCabe, F. L., Faucette, L. F., Johnson, R. K., et al. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00105a017 · Cited by 518
Natural Product Hybrids as New Leads for Drug Discovery
Tietze, L. F., Bell, H. P., & Chandrasekhar, S. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200553 · Cited by 516
García‐Carbonero, R., & Supko, J. G. (2002) · PubMed · Cited by 498
Natural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491
Advances in Cancer Therapy with Plant Based Natural Products
Mukherjee, A., Basu, S., Sarkar, N., & Ghosh, A. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372094 · Cited by 451
Blunt, J. W., Copp, B. R., Hu, W.-P., Munro, M. H. G., Northcote, P. T., & Prinsep, M. R. (2007) · Natural Product Reports · doi:10.1039/b603047p · Cited by 440
Total Synthesis of Baccatin III and Taxol
Danishefsky, S. J., Masters, J. J., Young, W. B., Link, J. T., Snyder, L. B., Magee, T. V., Jung, D. K., Isaacs, R. C. A., Bornmann, W. G., Alaimo, C. A., et al. (1996) · Journal of the American Chemical Society · doi:10.1021/ja952692a · Cited by 438
Blunt, J. W., Copp, B. R., Munro, M. H. G., Northcote, P. T., & Prinsep, M. R. (2006) · Natural Product Reports · doi:10.1039/b502792f · Cited by 418
Role of Curcumin in Cancer Therapy
Shishodia, S., Chaturvedi, M. M., & Aggarwal, B. B. (2007) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2007.04.001 · Cited by 413
Curcumin for chemoprevention of colon cancer
Johnson, J. J., & Mukhtar, H. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.03.005 · Cited by 396
Small Molecule Natural Products in the Discovery of Therapeutic Agents: The Synthesis Connection
Wilson, R. M., & Danishefsky, S. J. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo0610053 · Cited by 387
Plant-based anticancer molecules: A chemical and biological profile of some important leads
Srivastava, V., Negi, A., Kumar, J. K., Gupta, M. M., & Khanuja, S. P. S. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.05.066 · Cited by 379
Lignans; chemical, biological and clinical properties
(1991) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(91)90216-y · Cited by 376
Imbert, T. F. (1998) · Biochimie · doi:10.1016/s0300-9084(98)80004-7 · Cited by 350
HDAC inhibitors: Clinical update and mechanism-based potential
Glaser, K. B. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.04.007 · Cited by 348
Camptothecin and taxol: Discovery to clinic
Wall, M. E. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199809)18:5<299::aid-med2>3.0.co;2-o · Cited by 330
Lignans, neolignans, and related compounds
Ward, R. S. (1995) · Natural Product Reports · doi:10.1039/np9951200183 · Cited by 325
Camptothecins: from bench research to hospital wards.
Potmĕsil, M. (1994) · PubMed · Cited by 310
Topoisomerase I inhibitors: Review and update
Rothenberg, M. L. (1997) · Annals of Oncology · doi:10.1023/a:1008270717294 · Cited by 306
Antitumor Properties of Podophyllotoxin and Related Compounds
Gordaliza, M., Castro, M., Miguel del Corral, J., & San Feliciano, A. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003398582 · Cited by 268
Self-citationAltmann, K.-H., & Gertsch, J. (2007) · Nat. Prod. Rep. · doi:10.1039/b515619j · Cited by 248
Catharanthus terpenoid indole alkaloids: biosynthesis and regulation
El-Sayed, M., & Verpoorte, R. (2007) · Phytochemistry Reviews · doi:10.1007/s11101-006-9047-8 · Cited by 238
Taxol, a molecule for all seasons
Kingston, D. G. I. (2001) · Chemical Communications · doi:10.1039/b100070p · Cited by 233
Bayés, M., Rabasseda, X., & Prous, J. (2002) · PubMed · Cited by 200
Podophyllotoxin Derivatives: Current Synthetic Approaches for New Anticancer Agents
You, Y. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053764724 · Cited by 199
The story of taxol: nature and politics in the pursuit of an anti-cancer drug
(2001) · Choice Reviews Online · doi:10.5860/choice.39-0970 · Cited by 182
Clinical Pharmacokinetics of Topotecan
Herben, V. M. M., ten Bokkel Huinink, W. W., & Beijnen, J. H. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631020-00001 · Cited by 180
Lee, K.-H. (2004) · Journal of Natural Products · doi:10.1021/np030373o · Cited by 165
Samuelsson, G. (1992) · Cited by 163
HIGHLY ACTIVE ANTICANCER CURCUMIN ANALOGUES
Mosley, C. A., Liotta, D. C., & Snyder, J. P. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-46401-5_2 · Cited by 154
Bindra, J. S., & Lednicer, D. (1982) · American Chemical Society eBooks · Cited by 149
Magedov, I. V., Manpadi, M., slambrouck, S. V., Steelant, W. F. A., Николаевна, Р. Е., Пржевальский, Н. М., Rogelj, S., & Kornienko, A. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070528f · Cited by 145
Camptothecin and Podophyllotoxin Derivatives
Hartmann, J. T., & Lipp, H. (2006) · Drug Safety · doi:10.2165/00002018-200629030-00005 · Cited by 144
Podophyllotoxin derivatives: drug discovery and development
Bohlin, L., & Rosen, B. (1996) · Drug Discovery Today · doi:10.1016/1359-6446(96)10028-3 · Cited by 140
Wasserman, E., Cuvier, C., Lokiec, F. M., Goldwasser, F., Kalla, S., Méry-Mignard, D., Ould-Kaci, M., Besmaine, A., Dupont-André, G., Mahjoubi, M., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1751 · Cited by 134
Lignans, neolignans, and related compounds
Whiting, D. A. (1987) · Natural Product Reports · doi:10.1039/np9870400499 · Cited by 133
The shape of things to come: Structural and synthetic studies of taxol and related compounds
Kingston, D. G. I. (2006) · Phytochemistry · doi:10.1016/j.phytochem.2006.11.009 · Cited by 132
Tumor-Specific Novel Taxoid−Monoclonal Antibody Conjugates
Ojima, I., Geng, X., Wu, X., Qu, C., Borella, C. P., Xie, H., Wilhelm, S. D., Leece, B. A., Bartle, L. M., Goldmacher, V. S., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025540g · Cited by 116
Tumor Specific Novel Taxoid-Monoclonal Antibody Conjugates
Wu, X., & Ojima, I. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455963 · Cited by 115
DNA topoisomerase targeting drugs: mechanisms of action and perspectives
Malonne, H., & Atassi, G. (1997) · Anti-Cancer Drugs · doi:10.1097/00001813-199710000-00001 · Cited by 107
Will natural products remain an important source of drug research for the future?
Nisbet, L. J., & Moore, M. J. (1997) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(97)80124-3 · Cited by 105
Marine-derived anticancer agents in clinical trials
Schwartsmann, G., da Rocha, A. B., Mattei, J., & Lopes, R. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.8.1367 · Cited by 102
Lignans, neolignans, and related compounds
Whiting, D. A. (1990) · Natural Product Reports · doi:10.1039/np9900700349 · Cited by 100
Bergstralh, D. T., & Ting, J. P. ‐. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.01.004 · Cited by 94
Kuznetsova, L. V., Chen, J., Sun, L. D., Wu, X., Pepe, A., Veith, J. M., Pera, P. J., Bernacki, R. J., & Ojima, I. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.10.089 · Cited by 87
The role of taxanes in the treatment of breast cancer
Nabholtz, J., & Gligorov, J. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.7.1073 · Cited by 86
Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model
Busquets, S., Ametller, E., Fuster, G., Oliván, M., Raab, V., Argilés, J. M. A., & López-Soriano, F. J. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.12.035 · Cited by 81
Gymnastatins F−H, Cytostatic Metabolites from the Sponge-Derived Fungus Gymnascella dankaliensis
Amagata, T., Minoura, K., & Numata, A. (2006) · Journal of Natural Products · doi:10.1021/np0600189 · Cited by 78
Inhibitory Effects of Podophyllotoxin Derivatives on Herpes Simplex Virus Replication
Sudo, K., Konno, K., Shigeta, S., & Yokota, T. (1998) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029800900307 · Cited by 73
Marine natural products: synthetic aspects
Morris, J. C., & Phillips, A. J. (2008) · Natural Product Reports · doi:10.1039/b701533j · Cited by 69
Update on the Role of Topotecan in the Treatment of Recurrent Ovarian Cancer
Herzog, T. J. (2002) · The Oncologist · doi:10.1634/theoncologist.7-suppl_5-3 · Cited by 65
Molecular Pharmacokinetics of Catharanthus (Vinca) Alkaloids
Levêque, D., & Jehl, F. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007299430 · Cited by 64
Novel D-ring analogues of podophyllotoxin as potent anti-cancer agents
Subrahmanyam, D., Renuka, B., Rao, C. V., Sagar, P., Deevi, D. S., Babu, J. M., & Vyas, K. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00232-7 · Cited by 64
Design, synthesis, and cytostatic activity of novel cyclic curcumin analogues
Youssef, D., Nichols, C. E., Cameron, T. S., Balzarini, J. M., Clercq, E. D., & Jha, A. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.079 · Cited by 61
Natural Products as Leads for New Pharmaceuticals
Buss, A. D., Cox, B. J., & Waigh, R. D. (2003) · Wiley eBooks · doi:10.1002/0471266949.bmc018 · Cited by 54
Antibiotic resistance versus small molecules, the chemical evolution
LEE, V. J., & Hecker, S. J. (1999) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199911)19:6<569::aid-med7>3.0.co;2-9 · Cited by 46
Applications of total synthesis toward the discovery of clinically useful anticancer agents
Wilson, R. M., & Danishefsky, S. J. (2007) · Chemical Society Reviews · doi:10.1039/b611967k · Cited by 42
New Treatment Options for Colorectal Cancer
Erlichman, C., & Sargent, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejme048151 · Cited by 39
Doxorubicin generates a proapoptotic phenotype by phosphorylation of elongation factor 2
White, S. J., Kasman, L. M., Kelly, M. M., Lü, P., Spruill, L., McDermott, P. J., & Voelkel‐Johnson, C. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.06.015 · Cited by 38
Alimonti, A., Satta, F., Pavese, I., Burattini, E., Zoffoli, V., & Vecchione, A. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg193 · Cited by 37
Drug target interaction of tubulin-binding drugs in cancer therapy
Sengupta, S., & Thomas, S. A. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.10.1433 · Cited by 35
Marine natural products: synthetic aspects
Morris, J. C., Nicholas, G. M., & Phillips, A. J. (2007) · Natural Product Reports · doi:10.1039/b602832m · Cited by 32
Kamal, A., Gayatri, N. L., Reddy, D. R., Reddy, P. S. M. M., Arifuddin, M., Dastidar, S. G., Kondapi, A. K., & Rajkumar, M. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.06.032 · Cited by 31
Lee, C.-C., & Huang, T. (2001) · Pharmaceutical Research · doi:10.1023/a:1011048831698 · Cited by 28
Topotecan: what dose, what schedule, what route?
O’Reilly, S. (1999) · PubMed · Cited by 22
Khurdayan, V. K., Bozzo, J., & Prous, J. R. (2005) · Drug News & Perspectives · doi:10.1358/dnp.2005.18.8.953409 · Cited by 20
Combinatorial Solid-Phase Natural Product Chemistry
Mentel, M., & Breinbauer, R. (2007) · Springer eBooks · doi:10.1007/128_2006_107 · Cited by 19
Anticancer drug discovery and pharmaceutical chemistry: a history
Braña, M. F., & Sánchez‐Migallón, A. (2006) · Clinical & Translational Oncology · doi:10.1007/s12094-006-0118-5 · Cited by 10
Cited by
Kim, C., & Kim, B. (2018) · Nutrients · doi:10.3390/nu10081021 · Cited by 493
Farzaei, M. H., Zobeiri, M., Parvizi, F., El-Senduny, F. F., Marmouzi, I., Coy-Barrera, E., Naseri, R., Nabavi, S. M., Rahimi, R., & Abdollahi, M. (2018) · Nutrients · doi:10.3390/nu10070855 · Cited by 485
Plant derived substances with anti-cancer activity: from folklore to practice
Fridlender, M., Kapulnik, Y., & Koltai, H. (2015) · Frontiers in Plant Science · doi:10.3389/fpls.2015.00799 · Cited by 415
Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead
Martino, E., Casamassima, G., Castiglione, S., Cellupica, E., Pantalone, S., Papagni, F., Rui, M., Siciliano, A. M., & Collina, S. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.06.044 · Cited by 337
Silva-Carvalho, R., Baltazar, F., & Almeida-Aguiar, C. (2015) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2015/206439 · Cited by 333
Metadata
- Authors
- Gordaliza, M.
- Venue
- Clinical and Translational Oncology
- Published
- 2007-12
- Volume
- 9
- Issue
- 12
- Pages
- 767-776
- ISSN
- 1699-048X (ISSN-L)
- 1699-3055
- OpenAlex
- W1995398299
- Cited by
- 701
- References
- 87
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.